Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11-Reference-Cited by-同舟云学术

Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11

Published:2021-04 Issue: Volume:332 Page:517-528
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Mato-Berciano Ana,Morgado Sara,Maliandi María V.,Farrera-Sal Martí,Gimenez-Alejandre Marta,Ginestà Mireia M.,Moreno Rafael,Torres-Manjon Silvia,Moreno Paz,Arias-Badia Marcel,Rojas Luis A.,Capellà Gabriel,Alemany Ramon,Cascallo Manel,Bazan-Peregrino Miriam

Funder

Generalitat de Catalunya

Centro para el Desarrollo Tecnológico Industrial

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Advances in oncolytic adenovirus therapy for pancreatic cancer;Nattress;Cancer Lett.,2018

2. Oncolytic adenoviruses in cancer treatment;Alemany;Biomedicines,2014

3. Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth;Guedan;Mol. Ther.,2010

4. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications;Uusi-Kerttula;Viruses,2015

5. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations;Barouch;Vaccine,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies;Viruses;2024-06-17

2. Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations;Pharmacology & Therapeutics;2024-04

3. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner;Biomarker Research;2024-03-25

4. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

5. Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy;International Journal of Molecular Sciences;2024-01-18